The RNA-binding Protein HuR Confers Oxaliplatin Resistance of Colorectal Cancer by Upregulating CDC6
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0945
Full Text
Open PDFAbstract
Available in full text
Date
May 7, 2019
Authors
Publisher
American Association for Cancer Research (AACR)